Subject Inventions. CONTRACTOR and USER agree to disclose their Subject Inventions, which includes any inventions of their Participants, to each other, concurrent with reporting such Subject Inventions to DOE.
Subject Inventions. CONTRACTOR and USER agree to disclose their Subject Inventions, which include any inventions of their Participants, to each other, concurrent with reporting such Subject Inventions to DOE. The Parties agree that they will protect Subject Inventions from public disclosure for a reasonable period of time so that patent applications can be filed. CONTRACTOR employees are bound by the confidentiality requirements of their employer and the CONTRACTOR’s Prime Contract with DOE with respect to intellectual property disclosures.
Subject Inventions. Inventorship of any Project Intellectual Property which may be patentable under Title 35 U.S.C. (“Subject Invention”) will be determined in accordance with U.S.
Subject Inventions. The Grantee shall retain ownership of the entire right, title, and interest in and to each Subject Invention throughout the world in accordance with the provisions of this Agreement. The Grantor shall have a nonexclusive, nontransferable, irrevocable, paid-up license to practice, or have practiced for or on its behalf, the Subject Invention throughout the world.
Subject Inventions. Each Party shall promptly report to the other Party any Subject Invention, which report shall be accompanied by an invention disclosure that describes in reasonable detail the substance of the discovery or invention (a “Disclosure Report”). All rights to Subject Inventions conceived solely by employees, contractors, representatives or agents of NeuPharma will belong solely to NeuPharma (“NeuPharma Inventions”). All rights to Subject Inventions conceived solely by employees, contractors, representatives or agents of Company will belong solely to Company (“Company Inventions”‘). All rights to Subject Inventions conceived jointly by employees, contractors, representatives or agents of NeuPharma and employees or agents of Company will belong jointly to NeuPharma and Company (“Joint Inventions”). All NeuPharma Inventions Covering SRA Compounds shall be deemed included in Licensor Patents licensed to Company under the License Agreement. All Company Inventions outside the Territory Covering SRA Compounds shall be deemed included in Coronado Technology licensed to NeuPharma under the License Agreement. Except as expressly provided in this Agreement, it is understood that neither Party shall have any obligation to account to the other for profits, or to obtain any approval of the other Party to license, assign or otherwise exploit such jointly owned inventions or intellectual property, by reason of joint ownership thereof, and each Party hereby waives any right it may have under the laws of any jurisdiction to require any such approval or accounting.
Subject Inventions. The term “Subject Invention(s)” as used in this Agreement means any discovery, invention or other intellectual property that is conceived or authored by Inventor which is or will be disclosed and claimed in an application for Letters Patent, which has or will be executed by the Inventor and University which is entitled Int’l App’l No. , Filed , which claims benefit of U.S. Serial No. , Filed and which may be disclosed and claimed in any further application for Letters patent as defined in the “Patent Rights” below.
Subject Inventions. Inventorship of any invention or discovery which is conceived or first actually reduced to practice in the performance of this Project and which may be patentable under Title 35 U.S.C. (“Subject Invention”) will be determined in accordance with U.S.
Subject Inventions. The Center, on behalf of the U.S. Government, hereby grants to the Cooperator a first option to an exclusive license of the Government’s interest in each Subject Invention and in any resulting patents that issue on such Subject Inventions. This option must be exercised not later than six (6) months following the filing of a patent application in the U.S. Patent and Trademark Office or under the Patent Cooperation Treaty. Any exclusive license granted by EPA – Unilever U.K. Central Resources Limited XXXXX # 0000-00 UL PRN: MA-2020-00690N the Center shall be subject to the reservation by the U.S. Government of a nonexclusive, nontransferable, irrevocable paid-up license to practice or have practiced on its behalf the Subject Invention throughout the world, in accordance with 15 U.S.C. §3710a(b)(1).
Subject Inventions. The Contractor agrees to and does hereby grant to DBSI an irrevocable, non transferable and with no sublicensing rights, royalty-free, non-exclusive license to practice and have practiced Subject Inventions and patents issued thereon for ESAT Communication System purposes only throughout the world.
Subject Inventions. ISU grants to eMERGE an option to obtain a worldwide, royalty-bearing exclusive license to make, use and sell any ISU owned or Co-owned Subject Inventions. The option will expire unless:
